This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53961469
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel επιστημονικό άρθρο bilimsel makale artigo científico tieteellinen artikkeli naučni članak 1997年学术文章 articol științific 1997년 논문 vedecký článok 1997年学术文章 scientific article published in December 1997 научна статия article scientific teaduslik artikkel scientific article published in December 1997 artikel ilmiah 1997 nî lūn-bûn 1997年の論文 1997年學術文章 wissenschaftlicher Artikel scienca artikolo 1997年學術文章 articolo scientifico artikulong pang-agham научни чланак мақолаи илмӣ наукова стаття, опублікована в грудні 1997 tudományos cikk სამეცნიერო სტატია vitskapeleg artikkel article científic 1997年学术文章 scientific article published in December 1997 1997年學術文章 bài báo khoa học ডিসেম্বর ১৯৯৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ artigo científico מאמר מדעי artykuł naukowy artículo científico publicado en 1997 videnskabelig artikel 1997年学术文章 научни чланак vitenskapelig artikkel 1997年学术文章 1997年學術文章 vetenskaplig artikel 1997年學術文章 مقالة علمية نشرت في ديسمبر 1997 artikull shkencor artículu científicu vědecký článek 1997年学术文章 artigo científico article scientifique научная статья
p:P577
wds:Q53961469-EA0B329F-E151-420A-AA3D-4DE90646833C
wdt:P577
1997-12-01T00:00:00Z
p:P2860
wds:Q53961469-BF8461F3-C293-45F4-8A54-258DECFBD3B2 wds:Q53961469-362D33FD-4A9C-49E8-A6D1-88651B31CC0B wds:Q53961469-3FF63E00-E6AD-4B55-A3BE-A4F142459282 wds:Q53961469-5A65E02F-A2F9-4E34-9F47-EEA20807C584 wds:Q53961469-2539DB9C-D941-42E1-B221-BDF5E425F808 wds:Q53961469-039E1707-9C04-4D09-8A54-76C30B892857 wds:Q53961469-AFAD9F77-7AC6-499D-A6D3-1E68C0600277 wds:Q53961469-90C9B4A9-B63F-45EA-8663-38489BEC1B35 wds:Q53961469-9BFF170A-4C89-446B-B7D6-FBDCC5D618E5 wds:Q53961469-E548406F-DEEE-432E-B1F1-20E4358FDE55 wds:Q53961469-BB327902-D753-43D9-9EB7-78461A5AE225
wdt:P2860
wd:Q69696558 wd:Q44088836 wd:Q71018771 wd:Q69216132 wd:Q67985735 wd:Q54252036 wd:Q54125466 wd:Q54030471 wd:Q48241680 wd:Q48903818 wd:Q34396902
p:P2093
wds:Q53961469-0125DA09-1E38-46B4-A208-54BE4CA87D64 wds:Q53961469-234A5D7A-A66A-453E-BA62-CD7EEC5CABF8 wds:Q53961469-0D287571-5201-41BE-A4AF-5A191E60E82B wds:Q53961469-1FE562A3-F7D7-4E05-BC22-AC2ACB682EAA wds:Q53961469-50021EC4-25EA-493C-915F-A0443A91BBD4 wds:Q53961469-67C9F78C-472F-4A7E-A9E7-03BF1E6B6477 wds:Q53961469-5EF39145-365C-45D0-BAA1-BF890088DB09 wds:Q53961469-60E776DD-CD9F-454F-ACAE-14C62DFB4730 wds:Q53961469-7C7D0FEF-C479-4406-A97A-FC6C648F0915 wds:Q53961469-7F22B855-85E1-4471-96F1-F8E95057D7E6 wds:Q53961469-9A09A5B8-481F-4502-A15F-685F044E3DB1 wds:Q53961469-B3E61F3F-26A8-4787-925D-8E6718E75735 wds:Q53961469-EFCAFDCF-F56A-4BF7-8868-3DD1DEF9BA3B wds:Q53961469-F6E36E96-7D24-4C29-B47A-9A05F953B420
wdt:P2093
Palmini A Silva EA Vega-Gutiérrez L Reed UC Vizioli J Nunes ML Gherpelli JL Diament A Chisté MA Manreza ML Guerreiro MM Rotta NT Pedroso F Guerreiro CA
rdfs:label
Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
skos:prefLabel
Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
schema:name
Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
p:P50
wds:Q53961469-E3B2A655-9F41-47F7-964A-9307E7F21A9E
wdt:P50
wd:Q42861053
p:P1476
wds:Q53961469-8FD68DEE-264C-4273-AB9C-FCA5CE0F3EA6
wdt:P1476
Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
p:P304
wds:Q53961469-DA943110-C0AB-42CE-8B0C-D3FED63786BD
wdt:P304
1-6
p:P31
wds:Q53961469-63A7B47B-EC2B-4CFC-A8E2-D5D06AF19BF8
wdt:P31
wd:Q13442814
p:P698
wds:Q53961469-86A7543F-B048-4F1F-8B37-A91D0106FC5E
wdtn:P698
n12:9416454
wdt:P698
9416454
p:P1433
wds:Q53961469-A5C8E37A-4452-44A0-BF24-C4D98E336869
wdt:P1433
wd:Q15746405
p:P433
wds:Q53961469-A9972DCA-6454-44E7-863D-C322FA9778DD
p:P478
wds:Q53961469-FAB3BD25-1DA2-409B-BBCE-36E613264E1B
wdt:P433
1
wdt:P478
29
p:P356
wds:Q53961469-9312E563-03B1-45DF-91D3-2C3676F79BEA
wdtn:P356
n11:S0920-1211(97)00052-1
wdt:P356
10.1016/S0920-1211(97)00052-1